DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Citigroup Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces $69 Price Target

Citigroup analyst Neena Bitritto-Garg initiates coverage on ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy rating and a $69 price target.

Benzinga · 03/06/2020 09:54

Citigroup analyst Neena Bitritto-Garg initiates coverage on ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy rating and a $69 price target.